Hevert Dorm (Diphenhydramine Hydrochloride)

Hevert Dorm is indicated for several common allergic and sleep‑related conditions, typically for short‑term use under label guidance.

• Relief of symptoms associated with allergic rhinitis, such as sneezing, nasal congestion, and itchy eyes.
• Management of urticaria (hives) to reduce itching and skin rash.
• Short‑term treatment of occasional insomnia when a sedating antihistamine is appropriate.
• Prevention of motion‑sickness symptoms including nausea, vomiting, and dizziness.
• Adjunctive relief of mild cold‑related watery eyes and runny nose.

• Diphenhydramine hydrochloride acts as a competitive antagonist at peripheral H1 histamine receptors, preventing histamine‑mediated allergic responses. By crossing the blood‑brain barrier, it also blocks central H1 receptors, producing sedation. Additional anticholinergic activity contributes to its anti‑emetic and anti‑nausea effects, while the combined central H1 blockade underlies its utility as a short‑term sleep aid. The drug’s affinity for muscarinic receptors also explains some of its peripheral side‑effects, though these are not the primary therapeutic actions.

Like other first‑generation antihistamines, Hevert Dorm may cause a range of adverse reactions, most of which are mild and transient.

Common

• Drowsiness or sedation
• Dry mouth, throat, or nasal passages
• Dizziness or light‑headedness
• Nausea or mild stomach upset

Serious

• Severe allergic reaction (anaphylaxis) with rash, swelling, or breathing difficulty
• Rapid or irregular heartbeat (arrhythmia)
• Hallucinations, severe confusion, or extreme drowsiness affecting coordination
• Persistent urinary retention or difficulty urinating

Before using Hevert Dorm, consider the following precautions to minimize risks and ensure appropriate use.

• Avoid use if you have known hypersensitivity to diphenhydramine or other antihistamines.
• Do not operate machinery, drive, or perform hazardous tasks while experiencing sedation.
• Use with caution in patients with glaucoma, enlarged prostate, or urinary retention.
• Limit use during pregnancy or breastfeeding; consult a healthcare professional.
• Avoid concurrent use with alcohol or other central nervous system depressants.
• Do not exceed the recommended duration of short‑term use (typically 2‑3 nights) without medical advice.
• Assess for asthma or chronic obstructive pulmonary disease, as anticholinergic effects may worsen symptoms.

Hevert Dorm can interact with several medicines; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Avoid

• Other antihistamines or sedating antihistamine combinations, which may amplify drowsiness.
• Monoamine oxidase inhibitors (MAOIs) or recent MAOI therapy, due to risk of heightened anticholinergic effects.
• Certain antidepressants (e.g., tricyclics, SSRIs) that increase central nervous system depression.

Use with caution

• Alcohol, opioids, benzodiazepines, or sleep aids that also cause sedation.
• Anticholinergic drugs such as atropine, scopolamine, or certain antipsychotics.
• Medications that prolong the QT interval, including some antiarrhythmics and macrolide antibiotics.